ETF PROAI

JDOCvsLABU

JPMorgan Healthcare Leaders ETF against DIREXION DAILY S&P BIOTECH BULL 3X SHARES — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
JDOC 112LABU 265Oct 25Sep 26GROWTH OF $100
Head to head
JDOCLABU
Expense ratio0.65%—
Assets$9048.54T$594M
Net flow, 1 month—+$107M
Net flow, 1 year−$25K−$911M
Return, YTD+2.9%+66.8%
Return, 1 year+10.6%+164.6%
Avg daily volume241340K
Holdings67134
ListedOct 31, 2023Nov 27, 2023
Options marketNoYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.